Correlation Between Deciphera Pharmaceuticals and Cardiol Therapeutics
Can any of the company-specific risk be diversified away by investing in both Deciphera Pharmaceuticals and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deciphera Pharmaceuticals and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Deciphera Pharmaceuticals LLC and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Deciphera Pharmaceuticals and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deciphera Pharmaceuticals with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deciphera Pharmaceuticals and Cardiol Therapeutics.
Diversification Opportunities for Deciphera Pharmaceuticals and Cardiol Therapeutics
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Deciphera and Cardiol is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Deciphera Pharmaceuticals LLC and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Deciphera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deciphera Pharmaceuticals LLC are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Deciphera Pharmaceuticals i.e., Deciphera Pharmaceuticals and Cardiol Therapeutics go up and down completely randomly.
Pair Corralation between Deciphera Pharmaceuticals and Cardiol Therapeutics
Given the investment horizon of 90 days Deciphera Pharmaceuticals LLC is expected to under-perform the Cardiol Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Deciphera Pharmaceuticals LLC is 1.76 times less risky than Cardiol Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Cardiol Therapeutics Class is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 70.00 in Cardiol Therapeutics Class on September 4, 2024 and sell it today you would earn a total of 87.00 from holding Cardiol Therapeutics Class or generate 124.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 30.71% |
| Values | Daily Returns |
Deciphera Pharmaceuticals LLC vs. Cardiol Therapeutics Class
Performance |
| Timeline |
| Deciphera Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cardiol Therapeutics |
Deciphera Pharmaceuticals and Cardiol Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Deciphera Pharmaceuticals and Cardiol Therapeutics
The main advantage of trading using opposite Deciphera Pharmaceuticals and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deciphera Pharmaceuticals position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.| Deciphera Pharmaceuticals vs. ANI Pharmaceuticals | Deciphera Pharmaceuticals vs. Phibro Animal Health | Deciphera Pharmaceuticals vs. Prestige Brand Holdings | Deciphera Pharmaceuticals vs. Evotec SE ADR |
| Cardiol Therapeutics vs. Flora Growth Corp | Cardiol Therapeutics vs. ABVC Biopharma | Cardiol Therapeutics vs. Indaptus Therapeutics | Cardiol Therapeutics vs. HCW Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |